HUMBERTO BALDERRAMA: Open Payments
NPI 1215441886 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$982 in 46 payments from 7 companies in 2025. Trend: 2023 $342 · 2024 $909 · 2025 $982
Food & beverage: $943Education: $40
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $586 |
| Madrigal Pharmaceuticals | 6 | $175 |
| Novo Nordisk Inc | 2 | $135 |
| Janssen Biotech, Inc. | 1 | $33 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| Ardelyx, Inc. | 1 | $18 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
Products named: SKYRIZI, RINVOQ, REZDIFFRA, Wegovy, CREON, LINZESS, TREMFYA, VOQUEZNA.
Industry payments across TX — which companies pay providers there.
